Microbiome Technology and Analytics Hub for Autoimmune Conditions
Micro-TeACH (Microbiome Technology and Analytic Center Hub)
Learning whether microbes in the gut, skin, and mouth affect how people with autoimmune conditions like rheumatoid arthritis, psoriasis, lupus, and Sjogren’s respond to treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11307655 on NIH RePORTER |
What this research studies
Researchers at NYU will build and use advanced lab and computer tools to measure microbes from stool, skin, and oral samples and link those patterns to immune-driven diseases and treatment responses. The center will collect human samples and medical information, run high-resolution sequencing and other assays, and develop new analytic methods to find microbiome signals tied to who benefits from specific drugs. The hub will share technology, standardized methods, and data resources with other teams to speed up reproducible findings. Over time this work aims to create tests or models that could guide more personalized therapy choices for people with autoimmune diseases.
Who could benefit from this research
Good fit: Adults with autoimmune or immune-mediated conditions such as rheumatoid arthritis, psoriatic disease, lupus, or Sjogren’s who are willing to provide biological samples (stool, skin, or oral) and clinical information are ideal candidates.
Not a fit: People without autoimmune conditions or those unable or unwilling to provide samples and medical records are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this could help predict which patients will respond to particular autoimmune treatments and support more personalized care.
How similar studies have performed: Early studies have found promising links between the microbiome and treatment response, but translating these findings into reliable clinical tools is still new and not yet established.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Scher, Jose U. — New York University School of Medicine
- Study coordinator: Scher, Jose U.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.